Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

XENLETA Demonstrates High Efficacy in Community-Acquired Bacterial Pneumonia

americanpharmaceuticalreviewOctober 16, 2020

Tag: xenleta , pneumonia , CABP , Nabriva Therapeutics

PharmaSources Customer Service